External links
- Katie Ewer publications indexed by Google Scholar
| Development | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Classes | |||||||||||
| Administration | |||||||||||
| Vaccines |
| ||||||||||
| Inventors/ researchers | |||||||||||
| Controversy | |||||||||||
| Related | |||||||||||
| |||||||||||
Katie Ewer | |
|---|---|
| Academic background | |
| Education | PhD, Immunology, 2004, Open University |
| Thesis | Relationships between tuberculosis exposure, ex vivo antigen-specific T cell responses, and delayed type hypersensitivity in point-source outbreaks. (2004) |
| Academic work | |
| Institutions | University of Oxford |
Katie Jane Ewer is a British immunologist and Professor of Vaccine Immunology at the University of Oxford's Jenner Institute. [1]
When she did not get into medical school,Ewer pursued a career in biomedical science and became interested in infectious diseases. [2] She was interested in a career in biology for she was "fascinated by seemingly endless processes that occur in our cells and organs every second of our lives without us knowing about it. [2] Ewer earned an undergraduate degree in biomedical science,which included a year of microbiology training. [3] She then began working as a biomedical scientist at the microbiology department of the John Radcliffe Hospital in 2000, [4] before pursuing a PhD on the immunology of tuberculosis (TB). [3] Ewer earned her PhD at the Open University as a result of her research with Ajit Lalvani on novel diagnostic tools using T cells for the diagnosis of tuberculosis infection. [4]
Upon earning her PhD,Ewer joined the UK's Animal and Plant Health Agency where she studied the effectiveness of TB vaccines in cattle and managed the roll-out of interferon-gamma-based diagnosis for bovine TB in the UK herd for the Department for Environment,Food and Rural Affairs. [4] While in this role,she co-published Diagnosis of tuberculosis in South African children with a T cell-based assay:a prospective cohort study with Susan Liebeschuetz. [5]
In 2008,Ewer became a Senior Immunologist at Oxford University's Edward Jenner Institute for Vaccine Research. [4] While there,she continued to study the effects of TB on populations and led clinical trials in an effort to discover a vaccine for Ebola. [6] The aim of her research was to define vaccine-induced immunological parameters that correlate with protection from malaria and understand why vaccines do not always work as well as expected. [7] During the COVID-19 pandemic,she led clinical controlled trials in an effort to find a vaccine,which was published in a 2020 study titled Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2:a preliminary report of a phase 1/2,single-blind,randomised controlled trial. [8]
